SCHEMBL1310216

SCHEMBL1310216

O=CC=Cc1ccc(C=CC=O)cc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 2/20 0.75
▸ KDM4E B2RXH2 1/20 0.75
▸ MAPT P10636 1/20 0.75
▸ TRPA1 O75762 2/20 0.74
▸ LMNA P02545 1/20 0.74
▸ ALOX5 P09917 1/20 0.74
▸ MAPK1 P28482 1/20 0.74
▸ XDH P47989 2/20 0.58
▸ CDK4 P11802 3/20 0.50
▸ CCND1 P24385 3/20 0.50
▸ CCNB2 O95067 2/20 0.50
▸ CDK1 P06493 2/20 0.50
▸ CCNB1 P14635 2/20 0.50
▸ CCNB3 Q8WWL7 2/20 0.50
▸ APP P05067 5/20 0.46
▸ MAOB P27338 1/20 0.45
▸ GABBR2 O75899 1/20 0.41
▸ GABBR1 Q9UBS5 1/20 0.41
▸ MTNR1A P48039 1/20 0.37
▸ HDAC3 O15379 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1310214 1.00 ALDH1A1 (0.75) ALDH1A1KDM4EMAPTTRPA1LMNA
SCHEMBL1308773 0.91 ALDH1A1 (0.65) ALDH1A1KDM4EMAPTTRPA1LMNA
SCHEMBL1308775 0.91 ALDH1A1 (0.65) ALDH1A1KDM4EMAPTTRPA1LMNA
SCHEMBL4623249 0.89 ALDH1A1 (0.62) ALDH1A1KDM4EMAPTTRPA1LMNA
SCHEMBL4623252 0.89 ALDH1A1 (0.62) ALDH1A1KDM4EMAPTTRPA1LMNA
SCHEMBL566332 0.87 ALDH1A1 (0.60) ALDH1A1KDM4EMAPTTRPA1LMNA
SCHEMBL15624492 0.87 ALDH1A1 (0.60) ALDH1A1KDM4EMAPTTRPA1LMNA
SCHEMBL15624503 0.87 ALDH1A1 (0.60) ALDH1A1KDM4EMAPTTRPA1LMNA
SCHEMBL22306664 0.87 ALDH1A1 (0.60) ALDH1A1KDM4EMAPTTRPA1LMNA
P-Hydroxycinnamaldehyde SCHEMBL20912952 0.87 ALDH1A1 (1.00) ALDH1A1KDM4EMAPTTRPA1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12110453-B2 Acid injection and fracturing method for porous subterranean geological formation KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2024-10-08 — — US disclosed
US-12110454-B2 Downhole rock treatment method with corrosion inhibition KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2024-10-08 — — US disclosed
US-12104119-B2 Calcareous rock stimulation method KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2024-10-01 — — US disclosed
US-20240279534-A1 ACID INJECTION AND FRACTURING METHOD FOR POROUS SUBTERRANEAN GEOLOGICAL FORMATION KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2024-08-22 — — US disclosed
US-20240279535-A1 CALCAREOUS ROCK STIMULATION METHOD KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2024-08-22 — — US disclosed
US-20240271033-A1 DOWNHOLE ROCK TREATMENT METHOD WITH CORROSION INHIBITION KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2024-08-15 — — US disclosed
US-11987752-B2 Downhole acid stimulation method with corrosion inhibition KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2024-05-21 — — US disclosed
US-11795380-B2 Method for anti-corrosion treating an oil well with an oil in water emulsion KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2023-10-24 — — US disclosed
US-11781061-B2 Corrosion protection method for wellbore piping KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2023-10-10 — — US disclosed
US-11718918-B2 Method for inhibiting metal corrosion during acid cleaning or pickling KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2023-08-08 — — US disclosed
US-10626319-B1 Methods of inhibiting corrosion with a pyrazine corrosion inhibitor KING FAHD UNIVERSITY OF PETROLEUM AND MINERALS (SA) 2020-04-21 — — US disclosed
WO-2020046670-A1 CORROSION INHIBITOR COMPOSITIONS AND METHODS OF USE IN ACID STIMULATION OPERATIONS KAO CORPORATION (JP) 2020-03-05 — — WO disclosed
US-8216649-B2 Liquid crystal aligning agent, method of producing a liquid crystal alignment film and liquid crystal display device JSR CORPORATION (JP) 2012-07-10 — — US disclosed
US-8053577-B2 Derivatives of 5,9-methanocycloocta[b]pyridin-2-(1H)-one, their preparation and use as analgesics ZHANG HESHENG 2011-11-08 — — US disclosed
US-20110118422-A1 LIQUID CRYSTAL ALIGNING AGENT, METHOD OF PRODUCING A LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY DEVICE JSR CORPORATION (JP) 2011-05-19 — — US disclosed
US-20090118320-A1 DERIVATIVES OF 5,9-METHANOCYCLOOCTA[B]PYRIDIN-2-(1H)-ONE, THEIR PREPARATION AND USE AS ANALGESICS ZHANG HESHENG 2009-05-07 — — US disclosed
EP-2044937-A1 ANALGESIC 5, 9 - METHANOCYCLOOCTA (b) PYRIDIN - 2 (1H) - ONE DERIVATIVES, THEIR PREPARATION METHOD AND USE Tianjin Hemey Bio-Tech Co., Ltd. (CN) 2009-04-08 — — EP disclosed
US-7501166-B2 Liquid crystal panel and manufacturing method therefor SHARP KABUSHIKI KAISHA (JP) 2009-03-10 — — US disclosed
US-4835105-A Process for the preparation of high-purity gamma- and alpha-cyclodextrins CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) 1989-05-30 — — US disclosed
EP-0019899-B1 DERIVATIVES OF 3,4,5-TRIHYDROXYPIPERIDINE, PROCESSES FOR THEIR PREPARATION, AND THEIR USE AS MEDICINES AND IN ANIMAL FOOD BAYER AG (DE) 1984-07-18 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118320-A1 DERIVATIVES OF 5,9-METHANOCYCLOOCTA[B]PYRIDIN-2-(1H)-ONE, THEIR PREPARATION AND USE AS ANALGESICS CHRNA9, NR3C2, CBR3 ALDH1A1 1806/4885KDM4E 3356/4885MAPT 3559/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback